Prestige Consumer Healthcare Inc. Stock
There is no change in the price for Prestige Consumer Healthcare Inc. today.
Our community is currently high on Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 61 € shows a positive potential of 39.27% compared to the current price of 43.8 € for Prestige Consumer Healthcare Inc..
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 0.000% | -6.114% | -3.153% | -21.818% | -19.626% | -21.101% | -14.000% |
| Apollo Medical Holdings, Inc. | 0.000% | 8.387% | -13.846% | 32.283% | 58.491% | -2.326% | -43.529% |
| Petmed Express Inc | -4.290% | -9.819% | -10.186% | -41.553% | -46.535% | -85.909% | -93.568% |
| Suzuken Co Ltd | 0.000% | 2.256% | 0.000% | 8.800% | -17.073% | 8.800% | 8.800% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat